Global Equine Rhinopneumonitis Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 86

Published Date: 05 Jul 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Equine Rhinopneumonitis Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Equine Rhinopneumonitis Vaccine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Equine Rhinopneumonitis Vaccine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Equine Rhinopneumonitis Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Live
    Inactivated

Market segment by Application can be divided into
    Veterinary Pharmacy
    Online Sale
    Others

The key market players for global Equine Rhinopneumonitis Vaccine market are listed below:
    Zoetis
    Nisseiken Co., Ltd.
    Boehringer Ingelheim
    Santa Cruz Animal Health
    Merck

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Equine Rhinopneumonitis Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Equine Rhinopneumonitis Vaccine, with price, sales, revenue and global market share of Equine Rhinopneumonitis Vaccine from 2019 to 2021.
Chapter 3, the Equine Rhinopneumonitis Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Rhinopneumonitis Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Equine Rhinopneumonitis Vaccine market forecast, by regions, type and distribution channel, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Equine Rhinopneumonitis Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Equine Rhinopneumonitis Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Equine Rhinopneumonitis Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Live
        1.2.3 Inactivated
    1.3 Market Analysis by Distribution Channel
        1.3.1 Overview: Global Equine Rhinopneumonitis Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Veterinary Pharmacy
        1.3.3 Online Sale
        1.3.4 Others
    1.4 Global Equine Rhinopneumonitis Vaccine Market Size & Forecast
        1.4.1 Global Equine Rhinopneumonitis Vaccine Sales in Value (2016-2026))
        1.4.2 Global Equine Rhinopneumonitis Vaccine Sales in Volume (2016-2026)
        1.4.3 Global Equine Rhinopneumonitis Vaccine Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Equine Rhinopneumonitis Vaccine Production Capacity Analysis
        1.5.1 Global Equine Rhinopneumonitis Vaccine Total Production Capacity (2016-2026)
        1.5.2 Global Equine Rhinopneumonitis Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Equine Rhinopneumonitis Vaccine Market Drivers
        1.6.2 Equine Rhinopneumonitis Vaccine Market Restraints
        1.6.3 Equine Rhinopneumonitis Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 Zoetis
        2.1.1 Zoetis Details
        2.1.2 Zoetis Major Business
        2.1.3 Zoetis Equine Rhinopneumonitis Vaccine Product and Services
        2.1.4 Zoetis Equine Rhinopneumonitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Nisseiken Co., Ltd.
        2.2.1 Nisseiken Co., Ltd. Details
        2.2.2 Nisseiken Co., Ltd. Major Business
        2.2.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product and Services
        2.2.4 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Boehringer Ingelheim
        2.3.1 Boehringer Ingelheim Details
        2.3.2 Boehringer Ingelheim Major Business
        2.3.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product and Services
        2.3.4 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Santa Cruz Animal Health
        2.4.1 Santa Cruz Animal Health Details
        2.4.2 Santa Cruz Animal Health Major Business
        2.4.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product and Services
        2.4.4 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Merck
        2.5.1 Merck Details
        2.5.2 Merck Major Business
        2.5.3 Merck Equine Rhinopneumonitis Vaccine Product and Services
        2.5.4 Merck Equine Rhinopneumonitis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Equine Rhinopneumonitis Vaccine Sales by Manufacturer
    3.1 Global Equine Rhinopneumonitis Vaccine Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Equine Rhinopneumonitis Vaccine Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Equine Rhinopneumonitis Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Equine Rhinopneumonitis Vaccine Manufacturer Market Share
        3.4.2 Top 6 Equine Rhinopneumonitis Vaccine Manufacturer Market Share
    3.5 Global Equine Rhinopneumonitis Vaccine Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Equine Rhinopneumonitis Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Equine Rhinopneumonitis Vaccine Market Size by Region
        4.1.1 Global Equine Rhinopneumonitis Vaccine Sales in Volume by Region (2016-2026)
        4.1.2 Global Equine Rhinopneumonitis Vaccine Revenue by Region (2016-2026)
    4.2 North America Equine Rhinopneumonitis Vaccine Revenue (2016-2026)
    4.3 Europe Equine Rhinopneumonitis Vaccine Revenue (2016-2026)
    4.4 Asia-Pacific Equine Rhinopneumonitis Vaccine Revenue (2016-2026)
    4.5 South America Equine Rhinopneumonitis Vaccine Revenue (2016-2026)
    4.6 Middle East and Africa Equine Rhinopneumonitis Vaccine Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Equine Rhinopneumonitis Vaccine Sales in Volume by Type (2016-2026)
    5.2 Global Equine Rhinopneumonitis Vaccine Revenue by Type (2016-2026)
    5.3 Global Equine Rhinopneumonitis Vaccine Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Equine Rhinopneumonitis Vaccine Sales in Volume by Application (2016-2026)
    6.2 Global Equine Rhinopneumonitis Vaccine Revenue by Application (2016-2026)
    6.3 Global Equine Rhinopneumonitis Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Equine Rhinopneumonitis Vaccine Sales by Type (2016-2026)
    7.2 North America Equine Rhinopneumonitis Vaccine Sales by Application (2016-2026)
    7.3 North America Equine Rhinopneumonitis Vaccine Market Size by Country
        7.3.1 North America Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2016-2026)
        7.3.2 North America Equine Rhinopneumonitis Vaccine Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Equine Rhinopneumonitis Vaccine Sales by Type (2016-2026)
    8.2 Europe Equine Rhinopneumonitis Vaccine Sales by Application (2016-2026)
    8.3 Europe Equine Rhinopneumonitis Vaccine Market Size by Country
        8.3.1 Europe Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2016-2026)
        8.3.2 Europe Equine Rhinopneumonitis Vaccine Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Type (2016-2026)
    9.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Application (2016-2026)
    9.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size by Region
        9.3.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Equine Rhinopneumonitis Vaccine Sales by Type (2016-2026)
    10.2 South America Equine Rhinopneumonitis Vaccine Sales by Application (2016-2026)
    10.3 South America Equine Rhinopneumonitis Vaccine Market Size by Country
        10.3.1 South America Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2016-2026)
        10.3.2 South America Equine Rhinopneumonitis Vaccine Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Type (2016-2026)
    11.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Application (2016-2026)
    11.3 Middle East & Africa Equine Rhinopneumonitis Vaccine Market Size by Country
        11.3.1 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Equine Rhinopneumonitis Vaccine Typical Distributors
    12.3 Equine Rhinopneumonitis Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Equine Rhinopneumonitis Vaccine Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Equine Rhinopneumonitis Vaccine Revenue by Application, (USD Million), 2021-2026
    Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
    Table 4. Zoetis Major Business
    Table 5. Zoetis Equine Rhinopneumonitis Vaccine Product and Services
    Table 6. Zoetis Equine Rhinopneumonitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Nisseiken Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 8. Nisseiken Co., Ltd. Major Business
    Table 9. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product and Services
    Table 10. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 12. Boehringer Ingelheim Major Business
    Table 13. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product and Services
    Table 14. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Santa Cruz Animal Health Basic Information, Manufacturing Base and Competitors
    Table 16. Santa Cruz Animal Health Major Business
    Table 17. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product and Services
    Table 18. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Merck Basic Information, Manufacturing Base and Competitors
    Table 20. Merck Major Business
    Table 21. Merck Equine Rhinopneumonitis Vaccine Product and Services
    Table 22. Merck Equine Rhinopneumonitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Global Equine Rhinopneumonitis Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
    Table 24. Global Equine Rhinopneumonitis Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 25. Market Position of Manufacturers in Equine Rhinopneumonitis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 26. Global Equine Rhinopneumonitis Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
    Table 27. Head Office and Equine Rhinopneumonitis Vaccine Production Site of Key Manufacturer
    Table 28. Equine Rhinopneumonitis Vaccine New Entrant and Capacity Expansion Plans
    Table 29. Equine Rhinopneumonitis Vaccine Mergers & Acquisitions in the Past Five Years
    Table 30. Global Equine Rhinopneumonitis Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 31. Global Equine Rhinopneumonitis Vaccine Sales by Region (2021-2026) & (K Units)
    Table 32. Global Equine Rhinopneumonitis Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 33. Global Equine Rhinopneumonitis Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 34. Global Equine Rhinopneumonitis Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 35. Global Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (K Units)
    Table 36. Global Equine Rhinopneumonitis Vaccine Revenue by Type (2016-2021e) & (USD Million)
    Table 37. Global Equine Rhinopneumonitis Vaccine Revenue by Type (2021-2026) & (USD Million)
    Table 38. Global Equine Rhinopneumonitis Vaccine Price by Type (2016-2021e) & (US$/Unit)
    Table 39. Global Equine Rhinopneumonitis Vaccine Price by Type (2021-2026) & (US$/Unit)
    Table 40. Global Equine Rhinopneumonitis Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 41. Global Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (K Units)
    Table 42. Global Equine Rhinopneumonitis Vaccine Revenue by Application (2016-2021e) & (USD Million)
    Table 43. Global Equine Rhinopneumonitis Vaccine Revenue by Application (2021-2026) & (USD Million)
    Table 44. Global Equine Rhinopneumonitis Vaccine Price by Application (2016-2021e) & (US$/Unit)
    Table 45. Global Equine Rhinopneumonitis Vaccine Price by Application (2021-2026) & (US$/Unit)
    Table 46. North America Equine Rhinopneumonitis Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 47. North America Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026) & (K Units)
    Table 48. North America Equine Rhinopneumonitis Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 49. North America Equine Rhinopneumonitis Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 50. North America Equine Rhinopneumonitis Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 51. North America Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (K Units)
    Table 52. North America Equine Rhinopneumonitis Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 53. North America Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (K Units)
    Table 54. Europe Equine Rhinopneumonitis Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 55. Europe Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026) & (K Units)
    Table 56. Europe Equine Rhinopneumonitis Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 57. Europe Equine Rhinopneumonitis Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 58. Europe Equine Rhinopneumonitis Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 59. Europe Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (K Units)
    Table 60. Europe Equine Rhinopneumonitis Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 61. Europe Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (K Units)
    Table 62. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 63. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Region (2021-2026) & (K Units)
    Table 64. Asia-Pacific Equine Rhinopneumonitis Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 65. Asia-Pacific Equine Rhinopneumonitis Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 66. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 67. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (K Units)
    Table 68. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 69. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (K Units)
    Table 70. South America Equine Rhinopneumonitis Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 71. South America Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026) & (K Units)
    Table 72. South America Equine Rhinopneumonitis Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 73. South America Equine Rhinopneumonitis Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 74. South America Equine Rhinopneumonitis Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 75. South America Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (K Units)
    Table 76. South America Equine Rhinopneumonitis Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 77. South America Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (K Units)
    Table 78. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 79. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Country (2021-2026) & (K Units)
    Table 80. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 81. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 82. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 83. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Type (2021-2026) & (K Units)
    Table 84. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 85. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Application (2021-2026) & (K Units)
    Table 86. Direct Channel Pros & Cons
    Table 87. Indirect Channel Pros & Cons
    Table 88. Equine Rhinopneumonitis Vaccine Typical Distributors
    Table 89. Equine Rhinopneumonitis Vaccine Typical Customers
List of Figures
    Figure 1. Equine Rhinopneumonitis Vaccine Picture
    Figure 2. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Type in 2020
    Figure 3. Live
    Figure 4. Inactivated
    Figure 5. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Application in 2020
    Figure 6. Veterinary Pharmacy
    Figure 7. Online Sale
    Figure 8. Others
    Figure 9. Global Equine Rhinopneumonitis Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 10. Global Equine Rhinopneumonitis Vaccine Market Size and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Equine Rhinopneumonitis Vaccine Sales (2016-2026) & (K Units)
    Figure 12. Global Equine Rhinopneumonitis Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 13. Global Equine Rhinopneumonitis Vaccine Production Capacity (2016-2026) & (K Units)
    Figure 14. Global Equine Rhinopneumonitis Vaccine Production Capacity by Geographic Region: 2020 VS 2021
    Figure 15. Equine Rhinopneumonitis Vaccine Market Drivers
    Figure 16. Equine Rhinopneumonitis Vaccine Market Restraints
    Figure 17. Equine Rhinopneumonitis Vaccine Market Trends
    Figure 18. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Manufacturer in 2020
    Figure 19. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Manufacturer in 2020
    Figure 20. Equine Rhinopneumonitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 21. Top 3 Equine Rhinopneumonitis Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 22. Top 6 Equine Rhinopneumonitis Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 23. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Region (2016-2026)
    Figure 24. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Region (2016-2026)
    Figure 25. North America Equine Rhinopneumonitis Vaccine Revenue (2016-2026) & (USD Million)
    Figure 26. Europe Equine Rhinopneumonitis Vaccine Revenue (2016-2026) & (USD Million)
    Figure 27. Asia-Pacific Equine Rhinopneumonitis Vaccine Revenue (2016-2026) & (USD Million)
    Figure 28. South America Equine Rhinopneumonitis Vaccine Revenue (2016-2026) & (USD Million)
    Figure 29. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue (2016-2026) & (USD Million)
    Figure 30. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2016-2026)
    Figure 31. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Type (2016-2026)
    Figure 32. Global Equine Rhinopneumonitis Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 33. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2016-2026)
    Figure 34. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Application (2016-2026)
    Figure 35. Global Equine Rhinopneumonitis Vaccine Price by Application (2016-2026) & (US$/Unit)
    Figure 36. North America Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2016-2026)
    Figure 37. North America Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2016-2026)
    Figure 38. North America Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2016-2026)
    Figure 39. North America Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2016-2026)
    Figure 40. United States Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Canada Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Mexico Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2016-2026)
    Figure 44. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2016-2026)
    Figure 45. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2016-2026)
    Figure 46. Europe Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2016-2026)
    Figure 47. Germany Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. France Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. United Kingdom Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Russia Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Italy Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share by Region (2016-2026)
    Figure 53. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2016-2026)
    Figure 54. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Market Share by Region (2016-2026)
    Figure 55. Asia-Pacific Equine Rhinopneumonitis Vaccine Revenue Market Share by Region (2016-2026)
    Figure 56. China Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Japan Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Korea Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. India Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Southeast Asia Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Australia Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. South America Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2016-2026)
    Figure 63. South America Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2016-2026)
    Figure 64. South America Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2016-2026)
    Figure 65. South America Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2016-2026)
    Figure 66. Brazil Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Argentina Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2016-2026)
    Figure 69. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2016-2026)
    Figure 70. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2016-2026)
    Figure 71. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2016-2026)
    Figure 72. Turkey Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Egypt Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Saudi Arabia Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. South Africa Equine Rhinopneumonitis Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Sales Channel: Direct Channel vs Indirect Channel
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Zoetis
Nisseiken Co., Ltd.
Boehringer Ingelheim
Santa Cruz Animal Health
Merck

Related Reports

Global Equine Rhinopneumonitis Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Equine Rhinopneumonitis Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 17 Jan 2022

date Pharma & Healthcare

The Equine Rhinopneumonitis Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Equine Rhinopneumonitis Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Equine Rhinopneumonitis Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Equine Rhinopneumonitis Vaccine can prevent Equine Rhinopneumonitis，viruses that are prevalent in horses and can cause outbreaks of respiratory disease.

Global Equine Rhinopneumonitis Vaccine Supply, Demand and Key Producers, 2023-2029

Global Equine Rhinopneumonitis Vaccine Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

The global Equine Rhinopneumonitis Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Equine Rhinopneumonitis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Equine Rhinopneumonitis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Equine Rhinopneumonitis Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Equine Rhinopneumonitis Vaccine Supply, Demand and Key Producers, 2024-2030

Global Equine Rhinopneumonitis Vaccine Supply, Demand and Key Producers, 2024-2030

date 03 Mar 2024

date Pharma & Healthcare

The global Equine Rhinopneumonitis Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

equine rhinopneumonitis vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>